abstract |
Compounds having the formula R1, R2 and R3 are as defined in the present invention, and methods for producing and using such compounds, including using BMP1, TLL1 and / or TLL2 as inhibitors, and for treating diseases associated with BMP1, TLL1 and / or TLL2. |